115 related articles for article (PubMed ID: 38882295)
1. Lipidomics study of Liujunzi decoction in hyperlipidemia rats with spleen deficiency based on UPLC-Q-TOF/MS.
Sun S; Guo H; Shang E; Guo Q; Ju A; Li Y; Feng Y; Guo Y; Yang D; Lü S
Heliyon; 2024 Jun; 10(11):e31710. PubMed ID: 38882295
[TBL] [Abstract][Full Text] [Related]
2. [Spleen deficiency and phlegm dampness syndrome model in rats treated by Citri Reticulatae Pericarpium based on metabolomics].
Wu B; Shen MY; Chen HP; Liu YP; Wang F; Chen L
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4136-4147. PubMed ID: 36046904
[TBL] [Abstract][Full Text] [Related]
3. [Liujunzi Decoction treats 4NQO-induced esophageal cancer in mice: a study based on serum metabolomics].
Shang YW; Chen X; Wu YS; Zhou ZX; Liu Y; Liu YR; Hu XB; Chen YL
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):461-470. PubMed ID: 38403322
[TBL] [Abstract][Full Text] [Related]
4. [Contributions of flavonoids from citri reticulatae pericarpium to gastric hormones, CD3~+ and TFF3 mRNA expression in rats with spleen deficiency intervened by Liujunzi Decoction].
Lyu SW; Li Y; Yu X; Guo YY; Yang DY; Sun S; Shang EY
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):951-958. PubMed ID: 35285194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.
Zhang S; Zhao L; Wang H; Wang C; Huang S; Shen H; Wei W; Tao L; Zhou T
BMC Complement Altern Med; 2013 Mar; 13():54. PubMed ID: 23453018
[TBL] [Abstract][Full Text] [Related]
6. UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
Ma N; Karam I; Liu XW; Kong XJ; Qin Z; Li SH; Jiao ZH; Dong PC; Yang YJ; Li JY
Toxicol Appl Pharmacol; 2017 Oct; 332():40-51. PubMed ID: 28733207
[TBL] [Abstract][Full Text] [Related]
7. Insights into Q-markers of honey-fried licorice in treating spleen deficiency based on substance and energy metabolism regulation.
Xia W; Wang Y; Yue J; Fu X
Phytomedicine; 2024 May; 127():155498. PubMed ID: 38460491
[TBL] [Abstract][Full Text] [Related]
8. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
[TBL] [Abstract][Full Text] [Related]
9. Stigmasterol and gastrodin, two major components of banxia-baizhu-tianma decoction, alleviated the excessive phlegm-dampness hypertension by reducing lipid accumulation.
Zhang H; Sun Y; Zou Y; Chen C; Wang S
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117193. PubMed ID: 37726069
[TBL] [Abstract][Full Text] [Related]
10. [Identification of biomarkers in urine of rats with spleen Qi deficiency and biological significance].
Liu WP; Li CY; Huang J; Liao JZ; Ma WJ; Chen HY; Rui W
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4855-4863. PubMed ID: 29493158
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
[TBL] [Abstract][Full Text] [Related]
12. Identification of prototype compounds and their metabolites in rats' serum from Xuefu Zhuyu Decoction by UPLC-Q-TOF/MS.
Zhang X; Jiang Z; Zhang L; Xue C; Feng X; Chai X; Wang Y
Chin Herb Med; 2023 Jan; 15(1):139-150. PubMed ID: 36875444
[TBL] [Abstract][Full Text] [Related]
13. Xiangsha Liujunzi Decoction improves gastrointestinal motility in functional dyspepsia with spleen deficiency syndrome by restoring mitochondrial quality control homeostasis.
Zhang J; Wang X; Wang F; Tang X
Phytomedicine; 2022 Oct; 105():154374. PubMed ID: 35963194
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Xiangsha Liujunzi decoction on TLR signal pathway in gastric mucosa tissues of rats with Helicobacter pylori-induced chronic atrophic gastritis].
Lin ZQ; Wang DX; Hong SS; Fu XY
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3078-3083. PubMed ID: 28920352
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the antihyperlipidemic ingredients of Qi Ge Decoction based on metabolomics combined with serum pharmacochemistry.
Tang H; Guo KX; Huang KE; Li YF; Chen W; Wei HY; Yu XQ; Ke XH
Biomed Chromatogr; 2024 Jun; ():e5922. PubMed ID: 38867488
[TBL] [Abstract][Full Text] [Related]
16. [Lipid-lowering effect and mechanism of Danhong Injection on hyperlipidemia rats based on lipid metabolism disorder].
DU HX; Zhou HF; He Y; Wan HT; Yang JH
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3203-3210. PubMed ID: 32726030
[TBL] [Abstract][Full Text] [Related]
17. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of Didang Decoction in prevention of anti-atherosclerosis and hyperlipidemia by HPLC-Q-TOF-MS/MS and network pharmacology based on theory of "nutrients return to heart and fat accumulates in channels"].
Wu XZ; Kang J; Li Y; Pan JX
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(5):1352-1369. PubMed ID: 37005819
[TBL] [Abstract][Full Text] [Related]
19. UPLC-Q-TOF/MS based metabolomic profiling of serum and urine of hyperlipidemic rats induced by high fat diet.
Wu Q; Zhang H; Dong X; Chen XF; Zhu ZY; Hong ZY; Chai YF
J Pharm Anal; 2014 Dec; 4(6):360-367. PubMed ID: 29403901
[TBL] [Abstract][Full Text] [Related]
20. [Systematic review and Meta-analysis on efficacy and safety of Liujunzi Decoction combined with Western medicine for stable chronic obstructive pulmonary disease].
Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5331-5343. PubMed ID: 33350192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
